GPCR
Income statement / Annual
Last year (2023), Structure Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Structure Therapeutics Inc.'s net income was -$89.62 M.
See Structure Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$949,174.00 |
$623,258.00 |
$266,353.00 |
$20,034.00 |
| Gross Profit |
-$949,174.00 |
-$623,258.00 |
-$266,353.00 |
-$20,034.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$70.10 M
|
$36.19 M
|
$29,111.00
|
$12,364.00
|
| General & Administrative
Expenses |
$32.67 M
|
$16.37 M
|
$8,585.00
|
$3,542.00
|
| Selling & Marketing
Expenses |
$1.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$32.67 M
|
$16.37 M
|
$8,585.00
|
$3,542.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$102.78 M |
$52.56 M |
$37,696.00 |
$15,906.00 |
| Cost And Expenses |
$102.78 M |
$52.56 M |
$37,696.00 |
$15,906.00 |
| Interest Income |
$13.38 M |
$1.26 M |
$122.00 |
$168,289.00 |
| Interest Expense |
$13.39 M |
$0.00 |
$122,161.00 |
$0.00 |
| Depreciation &
Amortization |
$316,000.00
|
$623,258.00
|
$266,353.00
|
$20,034.00
|
| EBITDA |
-$102.46 M
|
-$52.28 M
|
-$37.62 M
|
-$15.75 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$13.39 M
|
$1.26 M
|
-$122,000.00
|
$168,000.00
|
| Income Before Tax |
-$89.38 M |
-$51.30 M |
-$37,818.00 |
-$15,738.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$236,000.00 |
$17,000.00 |
$231.00 |
$138.00 |
| Net Income |
-$89.62 M |
-$51.32 M |
-$38,049.00 |
-$15,876.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-2.44 |
-1.4 |
-0.001 |
-0.0004 |
| EPS Diluted |
-2.44 |
-1.4 |
-0.001 |
-0.0004 |
| Weighted Average Shares
Out |
$36.73 M
|
$36.59 M
|
$36.59 M
|
$36.59 M
|
| Weighted Average Shares
Out Diluted |
$36.73 M
|
$36.59 M
|
$36.59 M
|
$36.59 M
|
| Link |
|
|
|
|
